×
Embecta Net Profit Margin 2021-2024 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Embecta net profit margin from 2021 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Embecta Net Profit Margin 2021-2024 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Embecta net profit margin from 2021 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$120.6B
Cencora (COR)
$44.1B
ICON (ICLR)
$23.6B
DiDi Global (DIDIY)
$22.4B
Avantor (AVTR)
$17.7B
Revvity (RVTY)
$15.6B
Natera (NTRA)
$15.3B
Viatris (VTRS)
$13.9B
CochLear (CHEOY)
$12.8B
Solventum (SOLV)
$11.8B
Charles River Laboratories (CRL)
$10.2B
Medpace Holdings (MEDP)
$10.1B
Sonic Healthcare (SKHHY)
$9.1B
Doximity (DOCS)
$7.9B
HealthEquity (HQY)
$6.9B
Bausch + Lomb (BLCO)
$6.7B
PACS (PACS)
$6B
Organon (OGN)
$4.9B
Life Times (LTH)
$4.9B
Sotera Health (SHC)
$4.7B
Surgery Partners (SGRY)
$4.1B
Concentras Parent (CON)
$2.9B
Ardent Health Partners (ARDT)
$2.7B
GoodRx Holdings (GDRX)
$2.5B
BrightSpring Health Services (BTSG)
$2.5B
Alignment Healthcare (ALHC)
$2.1B
Premier (PINC)
$2B
Ryman Healthcare (RYHTY)
$2B
AMN Healthcare Services Inc (AMN)
$1.6B
CareDx (CDNA)
$1.6B